[APLS] QoQ Quarter Result on 31-Dec-2017 [#Q4]

Stock
[APLS] Apellis Pharmaceuticals, Inc.
Announcement Date
19-Mar-2018
Financial Year
2017
Quarter
31-Dec-2017 [#Q4]
Profit Trend
QoQ- -57.75%
YoY- -175.77%
Quarter Report
APLS's Result
APLS's Financial Summary
View:
Show?
Quarter Result
30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 CAGR
Revenue 0 0 0 12 0 0 0 -
PBT -35,972 -33,334 -21,736 -18,256 -11,573 -12,126 -9,051 150.69%
Tax -281 -33,669 267 -17,896 -11,589 -12,138 -9,063 -90.10%
NP -35,972 -33,334 -21,736 -18,256 -11,573 -12,126 -9,051 150.69%
Tax Rate - - - - - - - -
Total Cost 35,972 33,334 21,736 18,267 11,573 12,126 9,051 150.69%
Ratio Analysis
30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 CAGR
NP Margin 0.00 0.00 0.00 -158,169.26 0.00 0.00 0.00 -
Per Share
30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 CAGR
EPS -0.64 -0.61 -0.43 -0.36 -0.30 -0.67 -0.50 17.87%
EPS Diluted -0.64 -0.61 -0.43 -0.36 -0.30 -0.67 -0.50 17.87%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.